Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

When Seconds Count, Ultrasound-Based Location Technology Helps Protect Healthcare Workers

In the United States, more than 70% of all workplace assaults occur in the healthcare setting.1 Workplace violence is taking an increasing toll on hospitals and their staff in terms of injury, morale, cost, and reputation.

“Seconds count in a life-threatening situation and accurate location is essential to ensure immediate, effective response,” says Teresa Brasac, PhD, APRN, Chief Clinical and Informatics Officer, with Sonitor® Technologies, Inc. “Over 40% of nurses report an increase in physical violence and nearly 70% report an increase in verbal violence since 20202. Real Time Location systems (RTLS) with room and bay level accuracy can help to save a life or prevent serious injury.”

Sonitor’s SenseSafe™ solution, based on ultrasound technology, consistently delivers accurate and reliable location data, and provides the exact location of a staff member upon pressing a wearable duress button. The technology eliminates the possibility of responders looking for the staff member in distress on the wrong room or floor as can occur with the signal hopping characteristics of radio-based technologies. Sonitor’s SmartSafe™ wearable tags are designed to deliver a message every 2 seconds when a duress alarm is triggered by a button press and continue alarming until disarmed. The tags are embedded with the logic to identify their location, and to communicate over the facility’s Wi-Fi network within 1-3 seconds of when they move to a new location.

“Hospital leaders should carefully consider RTLS duress solutions that provide the most accurate location to protect their staff,” Dr. Brasac states. “For over 20 years, Sonitor has led the industry in developing and commercializing ultrasound based RTLS for healthcare. Our technology is installed in over 300 healthcare facilities around the world with over 1.5 million people and medical assets tagged. We understand the challenges faced by healthcare executives today and we partner with our customers to provide outcome driven solutions.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy